Summary Report from the Human Immunodeficiency Virus and Aging Consensus Project: Treatment Strategies for Clinicians Managing Older Individuals with the Human Immunodeficiency Virus

By 2015, most of the people living with the human immunodeficiency virus (HIV) in the United States will be aged 50 and older. Many will have known their HIV status for at least a decade, and most will have received antiretroviral therapy for some, if not all, of the time since testing positive. As...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American Geriatrics Society (JAGS) 2012-05, Vol.60 (5), p.974-979
Main Authors: Work Group for HIV and Aging Consensus Project, Work Group for the HIV and Aging Consensus Project
Format: Article
Language:English
Subjects:
Age Factors
Aged
Aging
AIDS
Anti-Retroviral Agents - therapeutic use
Biological and medical sciences
Consensus Development Conferences as Topic
General aspects
Geriatrics
Health care
Health participants
HIV
HIV Infections - complications
HIV Infections - drug therapy
Human immunodeficiency virus
Human viral diseases
Humans
Infectious diseases
Male
Medical sciences
Medicine
multimorbidity
Older people
Public health. Hygiene
Public health. Hygiene-occupational medicine
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:By 2015, most of the people living with the human immunodeficiency virus (HIV) in the United States will be aged 50 and older. Many will have known their HIV status for at least a decade, and most will have received antiretroviral therapy for some, if not all, of the time since testing positive. As these individuals advance in years, they frequently acquire diseases more commonly associated with aging than with HIV. This represents a unique challenge for today's medical providers. Although these individuals may appear considerably older than their chronological age, they are typically too young to see a geriatrician. An HIV specialist, although knowledgeable in the nuances of antiretroviral therapy, may be less comfortable managing multiple age‐related illnesses. Similarly, a geriatrician experienced in managing multiple, age‐related conditions may be less familiar with adjusting HIV‐related therapies. In this era of caring for older adults with HIV, these two medical disciplines are finding they have much to learn from each other.
ISSN:0002-8614
1532-5415
DOI:10.1111/j.1532-5415.2012.03948.x